These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21342079)

  • 1. Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.
    Jiménez-Nácher I; Alvarez E; Morello J; Rodriguez-Nóvoa S; de Andrés S; Soriano V
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):457-77. PubMed ID: 21342079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions with new hepatitis C oral drugs.
    Soriano V; Labarga P; Barreiro P; Fernandez-Montero JV; de Mendoza C; Esposito I; Benítez-Gutiérrez L; Peña JM
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):333-41. PubMed ID: 25553890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.
    Marfo K; Greenstein S
    Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin-antiretroviral interactions.
    Liedtke MD; Rathbun RC
    Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.
    Boffito M; Winston A; Jackson A; Fletcher C; Pozniak A; Nelson M; Moyle G; Tolowinska I; Hoetelmans R; Miralles D; Gazzard B
    AIDS; 2007 Jul; 21(11):1449-55. PubMed ID: 17589191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infections with human immunodeficiency viruses. Part II: Antiretroviral drugs, therapeutic options, and diagnostics].
    Stock I
    Med Monatsschr Pharm; 2011 Jul; 34(7):234-44; quiz 245-6. PubMed ID: 21809598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
    Esposito I; Labarga P; Barreiro P; Fernandez-Montero JV; de Mendoza C; Benítez-Gutiérrez L; Peña JM; Soriano V
    Expert Opin Drug Saf; 2015; 14(9):1421-34. PubMed ID: 26212044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
    Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
    AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe or life-threatening interactions between antiretrovirals and non-HIV drugs].
    Manzardo C; Tuset M; Miró JM; Gatell JM
    Enferm Infecc Microbiol Clin; 2015; 33(7):e15-30. PubMed ID: 24913990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral and immunosuppressive drug-drug interactions: an update.
    Izzedine H; Launay-Vacher V; Baumelou A; Deray G
    Kidney Int; 2004 Aug; 66(2):532-41. PubMed ID: 15253704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.
    Garvey L; Latch N; Erlwein OW; Mackie NE; Walsh J; Scullard G; McClure MO; Dickinson L; Back D; Winston A
    Antivir Ther; 2010; 15(2):213-8. PubMed ID: 20386076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral and statin drug-drug interactions.
    Ray GM
    Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and synergies from drug interactions.
    Sahai J
    AIDS; 1996 Nov; 10 Suppl 1():S21-5. PubMed ID: 8970672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological considerations in antiretroviral therapy.
    Sommadossi JP
    Antivir Ther; 1998; 3 Suppl 4():9-12. PubMed ID: 10723503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus.
    Mertz D; Battegay M; Marzolini C; Mayr M
    Am J Kidney Dis; 2009 Jul; 54(1):e1-4. PubMed ID: 19346040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive drugs in patients treated with antiretrovirals.
    Peyriere H; Eiden C; Macia JC; Reynes J
    Ann Pharmacother; 2012 May; 46(5):703-9. PubMed ID: 22550277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors and anticonvulsants.
    Brooks J; Daily J; Schwamm L
    AIDS Clin Care; 1997 Nov; 9(11):87, 90. PubMed ID: 11364776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between recreational drugs and antiretroviral agents.
    Antoniou T; Tseng AL
    Ann Pharmacother; 2002 Oct; 36(10):1598-613. PubMed ID: 12243611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among drugs for HIV and opportunistic infections.
    Piscitelli SC; Gallicano KD
    N Engl J Med; 2001 Mar; 344(13):984-96. PubMed ID: 11274626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.